US Stock MarketDetailed Quotes

SVRA Savara

Watchlist
  • 2.820
  • -0.010-0.35%
Close Feb 14 16:00 ET
  • 2.820
  • 0.0000.00%
Post 17:51 ET
483.97MMarket Cap-6.56P/E (TTM)

About Savara Company

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.

Company Profile

SymbolSVRA
Company NameSavara
Listing DateApr 29, 2004
Founded1995
CEOMr. Matthew Pauls, J.D.,M.B.A.
MarketNASDAQ
Employees37
Fiscal Year Ends12-31
AddressOne Summit Square,1717 Langhorne Newtown Road,Suite 300
CityLanghorne
ProvincePennsylvania
CountryUnited States of America
Zip Code19047
Phone1-512-614-1848
Websitehttp://www.savarapharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Matthew Pauls, J.D.,M.B.A.
  • Chairman of the Board and Chief Executive Officer
  • 3.76M
  • Dr. Raymond Pratt
  • Chief Medical Officer
  • --
  • Braden C. Parker
  • Chief Commercial Officer
  • --
  • David L. Lowrance
  • Chief Accounting Officer, Chief Financial and Administrative Officer
  • 1.52M
  • Anne Erickson
  • Chief Business Officer
  • --
  • Robert Lutz
  • Chief Operating Officer
  • 2.66M
  • Richard J. Hawkins
  • Independent Director
  • 149.13K
  • Dr. Joseph S. McCracken, D.V.M.
  • Lead Independent Director
  • 155.13K
  • Dr. An van Es-Johansson, M.D.
  • Independent Director
  • 155.63K
  • Nevan Charles Elam, J.D.
  • Independent Director
  • 157.63K
  • David A. Ray
  • Independent Director
  • 158.13K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!